Head and neck cancer

Proteomic advances and biomarker achievements

Authors

  • Taia Maria Berto Rezende PhD,

    1. Center of Proteomic and Biochemical Analyses, Post-Graduation in Biotechnology and Genomical Sciences, Catholic University of Brasilia, Brasilia-DF, Brazil
    Search for more papers by this author
  • Mirna de Souza Freire BS,

    1. Center of Proteomic and Biochemical Analyses, Post-Graduation in Biotechnology and Genomical Sciences, Catholic University of Brasilia, Brasilia-DF, Brazil
    Search for more papers by this author
  • Octávio Luiz Franco PhD

    Corresponding author
    1. Center of Proteomic and Biochemical Analyses, Post-Graduation in Biotechnology and Genomical Sciences, Catholic University of Brasilia, Brasilia-DF, Brazil
    • SGAN Quadra 916, Módulo B, Av. W5 Norte. 70.790-160-Brasília – DF, Brazil
    Search for more papers by this author
    • Fax: (011) 55-61-3347-4797


Abstract

Tumors of the head and neck comprise an important neoplasia group, the incidence of which is increasing in many parts of the world. Recent advances in diagnostic and therapeutic techniques for these lesions have yielded novel molecular targets, uncovered signal pathway dominance, and advanced early cancer detection. Proteomics is a powerful tool for investigating the distribution of proteins and small molecules within biological systems through the analysis of different types of samples. The proteomic profiles of different types of cancer have been studied, and this has provided remarkable advances in cancer understanding. This review covers recent advances for head and neck cancer; it encompasses the risk factors, pathogenesis, proteomic tools that can help in understanding cancer, and new proteomic findings in this type of cancer. Cancer 2010. © 2010 American Cancer Society.

Ancillary